| Product Name: | Meglumine antimonite injection |
| Brand Name: | Generic |
| Strength: | 1.5gm |
| Dosage Form: | Liquid Injection |
| Route of Administration: | IV (intravascular) |
| Packing: | 5 Ampoule of 5 ml |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anti leishmaniasis |
| Indication: | Meglumine antimoniate belongs to the group of medicines called antiprotozoals. Meglumine antimoniate is used to treat an infection called leishmaniasis (Bay sore or chiclero ulcer, espundia, kala-azar or black sickness, Oriental sore, ulcera de Bejuco, uta), which is caused by protozoa (tiny, one-celled organisms). |
| Storage: | After opening: the product must be used immediately. Before opening: no special precautions for storage. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Meglumine antimonite injection 5gm
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Meglumine antimoniate ………………………… 1.5000g
Corresponding amount of antimony ………..0.4050g
For a 5 ml ampoule.
THERAPEUTIC INDICATIONS:
Meglumine antimoniate belongs to the group of medicines called antiprotozoals. Meglumine antimoniate is used to treat an infection called leishmaniasis (Bay sore or chiclero ulcer, espundia, kala-azar or black sickness, Oriental sore, ulcera de Bejuco, uta), which is caused by protozoa (tiny, one-celled organisms).
CAUTION & SHEDULE:
Schedule H drug
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
storage: After opening: the product must be used immediately.
Before opening: no special precautions for storage.
Dosage:
Injection of 1 to 3 ml at the base of the lesion, repeated once (or twice in no apparent result), at intervals of 1 or 2 days.